Inflammasome Therapeutics announced it raised $3.8 Million in an amended filing from an offering of $3.8 Million
Inflammasome Therapeutics announced it raised $3.8 Million in an amended filing from an offering of $3.8 Million
01/26/24, 8:25 PM
Location
newtonMoney raised
$3.8 million
Industry
healthcare
Round Type
seed
Company Info
Location
57 chapel st.
newton, massachusetts, united states
Additional Info
Inflammasome Therapeutics is a science based company founded to develop therapies for prevalent, degenerative diseases such as Alzheimer’s disease, multiple sclerosis, macular degeneration, and Parkinson's disease.